Radiomic features in recurrent/metastatic platinum refractory head and neck squamous cell carcinoma treated with immunotherapy.

被引：1
|
作者：
Anile, Giuseppe
Bettinelli, Andrea
Paiusco, Marta
De Conti, Giorgio
Gottardi, Chiara
Conte, Pierfranco
Ghi, Maria Grazia
机构：
[1] Veneto Inst Oncol IOV IRCCS, Oncol Unit 2, Padua, Italy
[2] Univ Padua, Dept Informat Engn DEI, Padua, Italy
[3] Veneto Inst Oncol IOV IRCCS, Dept Med Phys, Padua, Italy
[4] Padua Univ, AOP, Dept Radiol, Padua, Italy
[5] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
[6] Veneto Inst Oncol IOV IRCCS, Oncol Unit 2, Padua, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18000
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Hsieh, Ronan W.
    Borson, Steven
    Tsagianni, Anastasia
    Zandberg, Dan P.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Immunotherapy in recurrent and or metastatic squamous cell carcinoma of the head and neck
    Saada-Bouzid, Esma
    Peyrade, Frederic
    Guigay, Joel
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 146 - 151
  • [3] Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
    Okada, Takuro
    Matsuki, Takashi
    Fushimi, Chihiro
    Okamoto, Isaku
    Sato, Hiroki
    Kondo, Takahito
    Tokashiki, Kunihiko
    Ito, Tatsuya
    Masubuchi, Tatsuo
    Tada, Yuichiro
    Miura, Kouki
    Hanyu, Kenji
    Omura, Go
    Takahashi, Hideki
    Yamashita, Taku
    Oridate, Nobuhiko
    Tsukahara, Kiyoaki
    ANTICANCER RESEARCH, 2022, 42 (10) : 4907 - 4912
  • [4] Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Lasniska, Izabela
    Kolenda, Tomasz
    Teresiak, Anna
    Lamperska, Katarzyna M.
    Galus, Lukasz
    Mackiewicz, Jacek
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 290 - 303
  • [5] Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck
    Recchia, Francesco
    Candeloro, Giampiero
    Di Staso, Mario
    Necozione, Stefano
    Bisegna, Roberta
    Bratta, Massimo
    Tombolini, Vincenzo
    Rea, Silvio
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (04) : 413 - 419
  • [6] Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
    Byoung Chul Cho
    Ki Chang Keum
    Sang Joon Shin
    Hye Jin Choi
    Young Joo Lee
    Se Hun Kim
    Eun Chang Choi
    Joo Hang Kim
    Cancer Chemotherapy and Pharmacology, 2009, 65 : 27 - 32
  • [7] Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
    Cho, Byoung Chul
    Keum, Ki Chang
    Shin, Sang Joon
    Choi, Hye Jin
    Lee, Young Joo
    Kim, Se Hun
    Choi, Eun Chang
    Kim, Joo Hang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 27 - 32
  • [8] Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Borel, Christian
    Jung, Alain C.
    Burgy, Mickael
    CANCERS, 2020, 12 (09) : 1 - 19
  • [9] Correlates of Cetuximab Efficacy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Previously Treated With Immunotherapy
    Park, Jong Chul
    Ahn, Jong Seok
    Merkin, Ross
    Patel, Manisha
    Wirth, Lori
    Roberts, Thomas J.
    JCO PRECISION ONCOLOGY, 2025, 9
  • [10] Platinum resistance and sensitivity in recurrent/metastatic head and neck squamous cell carcinoma
    Horichi, Yuto
    Matsui, Hidetoshi
    Yamamura, Yuta
    Iwae, Shigemichi
    AURIS NASUS LARYNX, 2024, 51 (01) : 132 - 137
12345